Studies have found that emetine not only has a certain antiviral effect, but also can reduce the inflammatory response of patients by inhibiting the activity of NF-κB through IκBα phosphorylation, and can also reduce pulmonary hypertension by regulating various cellular processes (88). Here, NFKB1 is linked to pulmonary arterial hypertension.